Skip to Main content Skip to Navigation
Journal articles

Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance

Abstract : Anti-apoptotic BCL-2 family members bind to BH3-only proteins and multidomain BAX/BAK to preserve mitochondrial integrity and maintain survival. Whereas inhibition of these interactions is the biological basis of BH3-mimetic anti-cancer therapy, the actual response of membrane-bound protein complexes to these compounds is currently ill-defined. Here, we find that treatment with BH3 mimetics targeting BCL-xL spares subsets of cells with the highest levels of this protein. In intact cells, sequestration of some pro-apoptotic activators (including PUMA and BIM) by full-length BCL-xL is much more resistant to derepression than previously described in cell-free systems. Alterations in the BCL-xL C-terminal anchor that impacts subcellular membrane-targeting and localization dynamics restore sensitivity. Thus, the membrane localization of BCL-xL enforces its control over cell survival and, importantly, limits the pro-apoptotic effects of BH3 mimetics by selectively influencing BCL-xL binding to key proapoptotic effectors.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-01416194
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Wednesday, December 14, 2016 - 10:56:19 AM
Last modification on : Monday, January 24, 2022 - 5:54:53 PM
Long-term archiving on: : Wednesday, March 15, 2017 - 1:10:54 PM

File

CellRep2016Eq8.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Jessie Pécot, Laurent A Maillet, Janic P Le Pen, Céline Vuillier, Sophie de Carné Trécesson, et al.. Tight Sequestration of BH3 Proteins by BCL-xL at Subcellular Membranes Contributes to Apoptotic Resistance. Cell Reports, Elsevier Inc, 2016, ⟨10.1016/j.celrep.2016.11.064⟩. ⟨inserm-01416194⟩

Share

Metrics

Record views

266

Files downloads

170